Dendritic Cell Targeting of Anthrax Vaccine
Dendritic Cell Targeting of Anthrax Vaccine
批准号:
7089026
负责人:
Mansour M Zadeh
金额:
$29.2万
依托单位国家:
美国
项目类别:
财政年份:
2004
资助国家:
美国
项目状态:
已结题
起止时间:
2004-09-30 至 2007-08-31
关键词:
B lymphocyteBacillus anthracisMacaca mulattaT lymphocyteanthraxanthrax toxinanthrax vaccinesantigen presentationbiotechnologybioterrorism /chemical warfarecellular immunitychimeric proteinshumoral immunityimmune responseleukocyte activation /transformationphage displaysubcutaneous drug administrationvaccine developmentvaccine evaluation
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Anthrax poses a significant threat as an agent of biological warfare. The current anthrax vaccine (AVA) requires multiple doses over an 18 month period. Therefore, in addition to the current vaccine, improved anthrax vaccine strategies will offer the public health. Antibodies to the protective antigen (PA) play an important role in specific immunity to anthrax. However, cell mediated immune responses are also important. Professional antigen presenting dendritic cells (DCs) possess the ability to elicit both humoral and cellular immune responses. These cells are poised to capture pathogens, migrate to draining lymph nodes, and select antigen-specific T cells to regulate T, B, and NK cells, macrophages and eosinophils, all of which may contribute to protective immunity. The objective of this proposal is to develop a novel vaccine strategy targeting anthrax PA directly to DCs. Recently we have shown that DCs induce significant T cell activation in vivo and in vitro. Moreover, our preliminary data demonstrate that recombinant PA activates DCs, inducing up-regulation of co-stimulatory molecules, and LC migration in vivo. We have generated peptides that specifically bind to DC subsets from a phage display library. We hypothesize that targeting PA directly to DCs will increase the levels and duration of a specific immune response resulting in better protection against anthrax. Thus, we will target PA to DCs by fusing it to DC-specific peptides. The specific aims of this proposal are 1: To determine whether targeting PA specifically to DCs enhances specific immune responses against B. anthracis PA and 2: To test whether PA-DC peptide fusion protein delivered by subcutaneous administration induces strong immune responses in the immune competent cells. This novel vaccine strategy to target specifically immunogenic PA to DCs via DC-binding peptides may enhance the immunogenicity of PA and thus elicit stronger immune responses against PA of B. anthracis.
期刊论文(4)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1089/vim.2006.19.602
发表时间:
2006
期刊:
Viral immunology
影响因子:
2.2
作者:
[M. Mohamadzadeh;Lieping Chen;G. Olinger;W. Pratt;A. Schmaljohn]
通讯作者:
M. Mohamadzadeh;Lieping Chen;G. Olinger;W. Pratt;A. Schmaljohn
Bacteria-associated VB12 regulates neonatal ileal epithelium homeostasis
-
批准号:10712066
-
项目类别:
-
资助金额:$38.51万
-
财政年份:2016
-
负责人:Mansour M Zadeh
-
依托单位:
Bacteria-associated VB12 regulates neonatal ileal epithelium homeostasis
-
批准号:10455546
-
项目类别:
-
资助金额:$34.88万
-
财政年份:2016
-
负责人:Mansour M Zadeh
-
依托单位:
Bacteria-associated VB12 regulates neonatal ileal epithelium homeostasis
-
批准号:10675544
-
项目类别:
-
资助金额:$34.88万
-
财政年份:2016
-
负责人:Mansour M Zadeh
-
依托单位:
Bacterial surface layer-specific immune protection against gut microbial infection
-
批准号:9252460
-
项目类别:
-
资助金额:$33.95万
-
财政年份:2016
-
负责人:Mansour M Zadeh
-
依托单位:
Bacterial surface layer-specific immune protection against gut microbial infection
-
批准号:9119312
-
项目类别:
-
资助金额:$35.07万
-
财政年份:2016
-
负责人:Mansour M Zadeh
-
依托单位:
Bacteria-associated VB12 regulates neonatal ileal epithelium homeostasis
-
批准号:10513600
-
项目类别:
-
资助金额:$34.88万
-
财政年份:2016
-
负责人:Mansour M Zadeh
-
依托单位:
Bacteria-associated VB12 regulates neonatal ileal epithelium homeostasis
-
批准号:10263275
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2016
-
负责人:Mansour M Zadeh
-
依托单位:
Bacteria-associated VB12 regulates neonatal ileal epithelium homeostasis
-
批准号:10117335
-
项目类别:
-
资助金额:$34.31万
-
财政年份:2016
-
负责人:Mansour M Zadeh
-
依托单位:
Novel multivalent vaccine for anthrax and botulinum
-
批准号:8509597
-
项目类别:
-
资助金额:$61.06万
-
财政年份:2011
-
负责人:Mansour M Zadeh
-
依托单位:
Novel multivalent vaccine for anthrax and botulinum
-
批准号:8707184
-
项目类别:
-
资助金额:$57.81万
-
财政年份:2011
-
负责人:Mansour M Zadeh
-
依托单位:
Novel multivalent vaccine for anthrax and botulinum
-
批准号:8368958
-
项目类别:
-
资助金额:$72.6万
-
财政年份:2011
-
负责人:Mansour M Zadeh
-
依托单位:
Novel multivalent vaccine for anthrax and botulinum
-
批准号:8321943
-
项目类别:
-
资助金额:$67.82万
-
财政年份:2011
-
负责人:Mansour M Zadeh
-
依托单位:
PEPTIDES INDENTIFIED THROUGH PHAGE DIRECT IMMUNOGENIC ANTIGEN TO DENDRITIC CELLS
-
批准号:7165090
-
项目类别:
-
资助金额:$3.6万
-
财政年份:2005
-
负责人:Mansour M Zadeh
-
依托单位:
Dendritic Cell Targeting of Anthrax Vaccine
-
批准号:6767264
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2004
-
负责人:Mansour M Zadeh
-
依托单位:
Dendritic Cell Targeting of Anthrax Vaccine
-
批准号:6953777
-
项目类别:
-
资助金额:$25.67万
-
财政年份:2004
-
负责人:Mansour M Zadeh
-
依托单位:
PHAGE DIRECT IMMUNOGENIC PEPTIDE IDENTIFICATION
-
批准号:6970811
-
项目类别:
-
资助金额:$4.62万
-
财政年份:2004
-
负责人:Mansour M Zadeh
-
依托单位:
NOVEL VACCINE STRATEGY TARGETING THE SIV NEF DIRECTLY TO DENDRITIC CELLS
-
批准号:6939787
-
项目类别:
-
资助金额:$6.15万
-
财政年份:2003
-
负责人:Mansour M Zadeh
-
依托单位:
PEPTIDES IDENTIFIED THROUGH PHAGE DISPLAY DIRECT ANTIGEN TO DENDRITIC CELLS
-
批准号:6939816
-
项目类别:
-
资助金额:$5.32万
-
财政年份:2003
-
负责人:Mansour M Zadeh
-
依托单位:
Dendritic cell targeted hepatitis c virus immunotherapy
-
批准号:6587549
-
项目类别:
-
资助金额:$14.85万
-
财政年份:2002
-
负责人:Mansour M Zadeh
-
依托单位:
海外基金